Paper29338446
The latest animal models of ovarian cancer for novel drug discovery.
Magnotti E and 1 other. Expert Opin Drug Discov, 2018. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. The latest animal models of ovarian cancer for novel drug discovery. Papers, record 29338446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29338446
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Ovarian Epithelial | Major topic |
| Ovarian Neoplasms | Major topic |
| Animals | |
| Disease Models, Animal | |
| Drug Design | |
| Drug Discovery | |
| Female | |
| Humans | |
| Mice | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| T32 CA207021 | NCI NIH HHS | United States | T32CA207021 | PubMed and NIH |
Source NIH RePORTER
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28146145 | Neutrophils dominate the immune cell composition in non-small cell lung cancer. | Nat Commun | 2017 | https://conductscience.org/library/papers/28146145 | PubMed |
| 2 | 24039628 | Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy. | Expert Rev Obstet Gynecol | 2012 | https://conductscience.org/library/papers/24039628 | PubMed |
| 3 | 14991899 | In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. | J Pathol | 2004 | https://conductscience.org/library/papers/14991899 | PubMed |
| 4 | 26298430 | Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer. | Cancer Immunol Immunother | 2015 | https://conductscience.org/library/papers/26298430 | PubMed |
| 5 | 19423762 | Three-dimensional ovarian organ culture as a tool to study normal ovarian surface epithelial wound repair. | Endocrinology | 2009 | https://conductscience.org/library/papers/19423762 | PubMed |
| 6 | 24798995 | NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer. | Dig Dis Sci | 2014 | https://conductscience.org/library/papers/24798995 | PubMed |
| 7 | 11506735 | Thermo-responsive culture dishes allow the intact harvest of multilayered keratinocyte sheets without dispase by reducing temperature. | Tissue Eng | 2001 | https://conductscience.org/library/papers/11506735 | PubMed |
| 8 | 27133165 | Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer. | Cell | 2016 | https://conductscience.org/library/papers/27133165 | PubMed |
| 9 | 19781107 | Ovarian cancer mouse models: a summary of current models and their limitations. | J Ovarian Res | 2009 | https://conductscience.org/library/papers/19781107 | PubMed |
| 10 | 26496815 | Genetically-defined ovarian cancer mouse models. | J Pathol | 2016 | https://conductscience.org/library/papers/26496815 | PubMed |
| 11 | 21135887 | Preclinical development of molecular-targeted agents for cancer. | Nat Rev Clin Oncol | 2010 | https://conductscience.org/library/papers/21135887 | PubMed |
| 12 | 25304260 | Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations. | Cancer Res | 2014 | https://conductscience.org/library/papers/25304260 | PubMed |
| 13 | 26350076 | Ovary and fimbrial stem cells: biology, niche and cancer origins. | Nat Rev Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26350076 | PubMed |
| 14 | 20811322 | In vivo imaging and therapeutic treatments in an orthotopic mouse model of ovarian cancer. | J Vis Exp | 2010 | https://conductscience.org/library/papers/20811322 | PubMed |
| 15 | 22327211 | Current advances in humanized mouse models. | Cell Mol Immunol | 2012 | https://conductscience.org/library/papers/22327211 | PubMed |
| 16 | 21720365 | Integrated genomic analyses of ovarian carcinoma. | Nature | 2011 | https://conductscience.org/library/papers/21720365 | PubMed |
| 17 | 27110559 | An Advanced Orthotopic Ovarian Cancer Model in Mice for Therapeutic Trials. | Biomed Res Int | 2016 | https://conductscience.org/library/papers/27110559 | PubMed |
| 18 | 25185190 | Patient-derived xenograft models: an emerging platform for translational cancer research. | Cancer Discov | 2014 | https://conductscience.org/library/papers/25185190 | PubMed |
| 19 | 24936477 | Tumor-associated macrophages contribute to tumor progression in ovarian cancer. | Front Oncol | 2014 | https://conductscience.org/library/papers/24936477 | PubMed |
| 20 | 1080543 | Thymus rudiment of the athymic nude mouse. | Nature | 1975 | https://conductscience.org/library/papers/1080543 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42323326 | Choline metabolism drives metastasis in BRCA1-deficient ovarian cancers by activating FAM3C. | Nat Commun | 2026 | https://conductscience.org/library/papers/42323326 | PubMed |
| 39228913 | PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39228913 | PubMed |
| 38001663 | Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts). | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38001663 | PubMed |
| 37344821 | Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37344821 | PubMed |
| 37258040 | Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. | J Immunother Cancer | 2023 | https://conductscience.org/library/papers/37258040 | PubMed |
| 36428724 | The Development of a Three-Dimensional Platform for Patient-Derived Ovarian Cancer Tissue Models: A Systematic Literature Review. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428724 | PubMed |
| 36185084 | Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/36185084 | PubMed |
| 35705879 | Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35705879 | PubMed |
| 35664756 | Patient-Derived Xenograft: A More Standard "Avatar" Model in Preclinical Studies of Gastric Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35664756 | PubMed |
| 35567348 | Topical pH Sensing NIR Fluorophores for Intraoperative Imaging and Surgery of Disseminated Ovarian Cancer. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35567348 | PubMed |
| 35565396 | Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35565396 | PubMed |
| 35267582 | A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations-Does One Model Type Fit All? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267582 | PubMed |
| 34918299 | Establishment of In Vivo Ovarian Cancer Mouse Models Using Intraperitoneal Tumor Cell Injection. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34918299 | PubMed |
| 34885064 | Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34885064 | PubMed |
| 34671560 | Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34671560 | PubMed |
| 34571921 | Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications. | Cells | 2021 | https://conductscience.org/library/papers/34571921 | PubMed |
| 34502278 | Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502278 | PubMed |
| 34065956 | Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer. | Cells | 2021 | https://conductscience.org/library/papers/34065956 | PubMed |
| 33940195 | Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model. | Acta Biomater | 2021 | https://conductscience.org/library/papers/33940195 | PubMed |
| 33918476 | Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33918476 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29338446
GET https://conductscience.org/api/papers/v1/29338446/references?page=2